Tehran University of Medical Sciences

Science Communicator Platform

Share By
Considerations for Interactions of Drugs Used for the Treatment of Covid-19 With Anti-Cancer Treatments Publisher Pubmed



Jafari A1 ; Dadkhahfar S2 ; Perseh S3
Authors

Source: Critical Reviews in Oncology/Hematology Published:2020


Abstract

SARS-CoV2 infection is an emerging issue worldwide. Cancer patient are at increased risk of infection compared to general population. On the other hand, these patients are at major risk of drug interactions caused by renal and hepatic impairment background. Because of the long-term use of chemotherapy drugs, drug interactions are important in these patients especially with SARS-CoV2 treatments now. This paper is review of reported drug interactions of current treatments for COVID-19 and anticancer agents. © 2020 Elsevier B.V.
Related Docs
View other Related Docs
1. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)
2. Challenges Posed by Covid-19 in Cancer Patients: A Narrative Review, Cancer Medicine (2022)
3. Sars-Cov-2 Infection in Cancer Patients, Susceptibility, Outcome and Care, American Journal of the Medical Sciences (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (5)
Maryam Nasimi (1)
Other Related Docs
4. Covid-19: A Review on Treatment Strategies and Candidate Vaccines, Scientific Journal of Kurdistan University of Medical Sciences (2021)
5. Covid-19 in Patients With Cancer, Advances in Experimental Medicine and Biology (2021)
6. Potential Therapeutic Options for Covid-19: An Update on Current Evidence, European Journal of Medical Research (2022)
7. Prophylaxis With Chloroquine and Hydroxychloroquine in Covid-19, Journal of Iranian Medical Council (2020)
8. A Meta-Analysis for Prevalence of Lung Cancer Patients With Sars-Cov-2 Infection During the Covid-19 Pandemic, Eurasian Journal of Medicine and Oncology (2022)
9. Real Clinical Practice and Therapeutic Management Following Covid-19 Crisis in Two Hospitals in Iran: A Statistical and Conceptual View, Tanaffos (2020)
10. Computational Drug Discovery and Repurposing for the Treatment of Covid-19: A Systematic Review, Bioorganic Chemistry (2021)
11. Virtual Screening Based on the Structure of More Than 105 Compounds Against Four Key Proteins of Sars-Cov-2: Mpro, Srbd, Rdrp, and Plpro, Informatics in Medicine Unlocked (2022)
12. Covid-19: Why Does Disease Severity Vary Among Individuals?, Respiratory Medicine (2021)
13. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
14. Covid-19: Review of a 21St Century Pandemic From Etiology to Neuro-Psychiatric Implications, Journal of Alzheimer's Disease (2020)
15. The Contributory Role of Lymphocyte Subsets, Pathophysiology of Lymphopenia and Its Implication As Prognostic and Therapeutic Opportunity in Covid-19, International Immunopharmacology (2021)
16. Biochemical Parameters and Pathogenesis of Sars-Cov-2 Infection in Vital Organs: Covid-19 Outbreak in Iran, New Microbes and New Infections (2020)
17. Oral Antiviral Treatments for Covid-19: Opportunities and Challenges, Pharmacological Reports (2022)
18. Sars-Cov-2 and Covid-19, Evidence From a Literature Review: Review Article, Tehran University Medical Journal (2021)
19. Human Coronaviruses Sars-Cov, Mers-Cov, and Sars-Cov-2 in Children, Journal of Pediatric Nursing (2021)
20. Therapeutic Status of Famotidine in Covid-19 Patients: A Review, Infectious Disorders - Drug Targets (2022)